Krempa David bought ETON
July 12, 2026 · Form 4 insider transaction
Krempa David bought 10,000 shares of Eton Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
N/A
Total value
N/A
InsiderKrempa David
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 12, 2026
Filing dateJuly 13, 2026
Shares owned after37,025
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On July 12, 2022, the reporting person was granted 40,000 restricted stock units which vested in four equal annual installments beginning July 12, 2023.